Climb Bio (CLYM) Property, Plant & Equipment (Net) (2024 - 2026)

Climb Bio (CLYM) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Climb Bio 877.15 Mn 877.15 Mn - 250,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 250,000.00
Mar 31, 2026 250,000.00
Dec 31, 2025 288,000.00
Dec 31, 2025 288,000.00
Sep 30, 2025 318,000.00
Sep 30, 2025 318,000.00
Jun 30, 2025 314,000.00
Jun 30, 2025 314,000.00
Dec 31, 2024 199,000.00
Dec 31, 2024 199,000.00